(Hypertension. 1995;25:1025-1029.)
© 1995 American Heart Association, Inc.
Articles |
Role of Endogenous Endothelins in the Renin System of Normal and Two-Kidney, One Clip Rats
From the Physiologisches Institut der Universität Regensburg (Germany) (K.S., H.S., M.H., A.K.); F. Hoffmann–La Roche Ltd, Basel, Switzerland (M.C.); and the Klinik und Poliklinik für Innere Medizin II, Universität Regensburg (Germany) (B.K.K.).
Correspondence to Dr Karin Schricker, Institut für Physiologie I, Universität Regensburg, Postfach 101042, 93040 Regensburg, FRG.
Abstract This study aimed to investigate the relevance of endogenous endothelins in the control of renin secretion and renin gene expression under basal conditions and stimulated conditions achieved with unilateral renal artery stenosis. To this end, we studied the effects of the orally active endothelin antagonist Ro 47-0203 (100 mg/kg per day) for 2 days on plasma renin activity and renal renin mRNA levels in normal rats and rats with unilateral renal artery clips (0.2 mm). Treatment with Ro 47-0203 did not change basal arterial pressure but significantly attenuated the rise of blood pressure in response to renal artery clipping. Although Ro 47-0203 tended to increase basal plasma renin activity, this effect was not significant. Basal renin mRNA levels of kidneys were also not changed by the drug. Unilateral renal artery clipping increased plasma renin activity from 12 to 34 ng angioten-sin I/mL per hour, increased renin mRNA levels to 328% of controls in the clipped kidneys, and decreased renin mRNA levels to 23% of controls in the contralateral intact kidneys. These changes were not influenced by Ro 47-0203. In isolated perfused rat kidneys, Ro 47-0203 (10 µmol/L) also had no effect on basal renin secretion or vascular resistance, but it substantially attenuated the decrease of renin secretion and renal flow in response to administration of exogenous endothelin. Taken together, these findings suggest that endogenous endothelins play no relevant role in the control of renin secretion and of renin gene expression in normal and hypoperfused rat kidneys.
Key Words: blood pressure • juxtaglomerular cells • endothelium • endothelins • renin
This article has been cited by other articles:
 |
|
 |
|
  A. Riggleman, J. Harvey, and C. Baylis Endothelin Mediates Some of the Renal Actions of Acutely Administered Angiotensin II Hypertension, July 1, 2001; 38(1): 105 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Bianciotti and A. J. de Bold Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension Cardiovasc Res, March 1, 2001; 49(4): 808 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Kammerl, D. Grimm, C. Nabel, F. Schweda, M. Bach, S. Fredersdorf, H. Piehler, S. R. Holmer, G. A. J. Riegger, E. P. Kromer, et al. Effects of growth hormone on renal renin gene expression in normal rats and rats with myocardial infarction Nephrol. Dial. Transplant., June 1, 2000; 15(6): 786 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Rossi, A. Sacchetto, D. Rizzoni, S. Bova, E. Porteri, G. Mazzocchi, A. S. Belloni, M. Bahcelioglu, G. G. Nussdorfer, and A. C. Pessina Blockade of Angiotensin II Type 1 Receptor and Not of Endothelin Receptor Prevents Hypertension and Cardiovascular Disease in Transgenic (mREN2)27 Rats via Adrenocortical Steroid-Independent Mechanisms Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schweda, F. C. Blumberg, A. Schweda, M. Kammerl, S. R. Holmer, G. A. J. Riegger, M. Pfeifer, and B. K. Kramer Effects of chronic hypoxia on renal renin gene expression in rats Nephrol. Dial. Transplant., January 1, 2000; 15(1): 11 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Rossi, A. Sacchetto, M. Cesari, and A. C Pessina Interactions between endothelin-1 and the renin-angiotensin-aldosterone system Cardiovasc Res, August 1, 1999; 43(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Berthold, K. Munter, A. Just, H. R. Kirchheim, and H. Ehmke Stimulation of the Renin-Angiotensin System by Endothelin Subtype A Receptor Blockade in Conscious Dogs Hypertension, June 1, 1999; 33(6): 1420 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ehmke, J. Faulhaber, K. Munter, M. Kirchengast, and R. J. Wiesner Chronic ETA Receptor Blockade Attenuates Cardiac Hypertrophy Independently of Blood Pressure Effects in Renovascular Hypertensive Rats Hypertension, April 1, 1999; 33(4): 954 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sutsch, W. Kiowski, X.-W. Yan, P. Hunziker, S. Christen, W. Strobel, J.-H. Kim, P. Rickenbacher, and O. Bertel Short-Term Oral Endothelin-Receptor Antagonist Therapy in Conventionally Treated Patients With Symptomatic Severe Chronic Heart Failure Circulation, November 24, 1998; 98(21): 2262 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Haynes, C. J. Ferro, D. J. Webb, B. K. Kramer, F. Schweda, G. A.J. Riegger, H. Krum, Y. Lacourciere, and V. Charlon Bosentan in Essential Hypertension N. Engl. J. Med., July 30, 1998; 339(5): 346 - 347. [Full Text]
|
|
|
|
|
|
A. Herizi, B. Jover, N. Bouriquet, and A. Mimran Prevention of the Cardiovascular and Renal Effects of Angiotensin II by Endothelin Blockade Hypertension, January 1, 1998; 31(1): 10 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. d'Uscio, P. Moreau, S. Shaw, H. Takase, M. Barton, and T. F. Luscher Effects of Chronic ETA-Receptor Blockade in Angiotensin II-Induced Hypertension Hypertension, January 1, 1997; 29(1): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Li, L. Y. Deng, K. Grove, C. F. Deschepper, and E. L. Schiffrin Comparison of Effect of Endothelin Antagonism and Angiotensin-Converting Enzyme Inhibition on Blood Pressure and Vascular Structure in Spontaneously Hypertensive Rats Treated With N{omega}-Nitro-L-Arginine Methyl Ester: Correlation With Topography of Vascular Endothelin-1 Gene Expression Hypertension, August 1, 1996; 28(2): 188 - 195. [Abstract] [Full Text]
|
|